Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 3Phase NA 2Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 4Sarcoma 2Triple Negative Breast Neoplasms 1Sarcoma, Synovial 1Pheochromocytoma 1Neurofibrosarcoma 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Histiocytoma, Malignant Fibrous 1Hematologic Neoplasms 1Fibrosarcoma 1Breast Neoplasms, Male 1

Interventions

Ifosfamide 8Doxorubicin 8Blood Specimen Collection 8Radiosurgery 7Proton Therapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Standard of Care 4Radiotherapy 4Magnetic Resonance Spectroscopy 4X-Rays 3Vincristine 3Radiation Dose Hypofractionation 3Palliative Care 3Methods 3Mesna 3pegfilgrastim 2pazopanib 2dexamethasone acetate 2Trastuzumab 2Transurethral Resection of Bladder 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Protons 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Methotrexate 2Melphalan 2Heavy Ion Radiotherapy 2Gene Expression Profiling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Sarcoma × pegfilgrastim × Clear all
NCT00346125 2022-12-15

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
70 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00283621 2018-11-07

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡